SCHEMBL22249798

SCHEMBL22249798

Nc1cnc2oc3cc4c5ccccc5c5ccccc5c4cc3c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.42
RAB9A P51151 5/20 0.42
NPC1 O15118 5/20 0.42
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 4/20 0.42
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 2/20 0.41
PARP1 P09874 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
GSK3B P49841 2/20 0.33
ALDH2 P05091 1/20 0.33
GFER P55789 1/20 0.33
AHR P35869 1/20 0.32
NQO1 P15559 1/20 0.32
ADRB2 P07550 1/20 0.31
LIMK1 P53667 1/20 0.31
CCNE2 O96020 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3375737 0.85 KDM4E (0.55) KMT2ARAB9ANPC1ALDH1A1MEN1
SCHEMBL22250026 0.81 IDO1 (0.39) KMT2AALDH1A1MEN1KDM4EHPGD
SCHEMBL22249796 0.75 KDM4E (0.36) KMT2ANPC1ALDH1A1MEN1KDM4E
SCHEMBL22249685 0.75 MEN1 (0.48) KMT2ARAB9ANPC1ALDH1A1MEN1
SCHEMBL25662820 0.73 NPC1 (0.32) RAB9ANPC1MAPTSMN1; SMN2GFER
SCHEMBL22249696 0.72 LPL (0.37) GSK3BALDH2
SCHEMBL22250033 0.70 GSK3B (0.34) KMT2ARAB9ANPC1MAPK1PARP1
SCHEMBL22250080 0.70 AHR (0.38) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL20172259 0.67 NPC1 (0.58) KMT2ARAB9ANPC1ALDH1A1MEN1
SCHEMBL24039795 0.67 AHR (0.63) KMT2ARAB9ANPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 KMT2A 3007/4885RAB9A 3264/4885NPC1 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.